Page last updated: 2024-08-24

duloxetine and nomifensine

duloxetine has been researched along with nomifensine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, JP; Crocker, PJ; Curry, MA; Harms, AE; Hassler, C; Kitchen, DB; Klos, AM; Laws, M; Liu, S; Molino, BF; Olson, RE; Opalka, C; Pechulis, AD; Smith, MA; Sweet, MP; Vellekoop, AS; Wolf, MA; Xi, N; Yang, Z1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for duloxetine and nomifensine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for duloxetine and nomifensine

ArticleYear
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kinetics; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Tetrahydroisoquinolines

2012